About Careers MedBlog Contact us

How Much Statins Should be Given to Patients with Heart Disease?

by Dr. Trupti Shirole on April 2, 2015 at 6:58 AM
Font : A-A+

How Much Statins Should be Given to Patients with Heart Disease?

Statins are medicines that help lower the cholesterol levels in the blood. Given that heart disease tops the mortality charts, to use statins or not is one of the most important questions faced by patients and physicians alike. A new report by Johns Hopkins University offers concrete tips for physicians on how to conduct this vital discussion and to reduce patient uncertainty and frustration in making this complicated decision.

The American Heart Association guidelines recommend the use of a complex equation to determine a patient's risk of heart disease. This calculation takes into consideration cholesterol levels and other aspects of the patient's health. The final number gives the doctor a risk number for that patient, which is then used to determine whether statin therapy should be recommended.


Author Neil J. Stone said, "The decision should be informed by the intersection of scientific evidence, clinical judgment and patient preference, but clinicians need to individualize the advice. It's a simple concept- making sure they're not treating the disease but the person with the disease, and, in this case, those at elevated risk for it. Done the right way, this is precision medicine at its best."

The tips for clinicians to help patients make the right call whether to use cholesterol-lowering statins or not, include:

1. Do not get fixated on a number, but ask patients to use the risk-score calculator prior to their visit and come armed with questions.

2. Shared decision-making does not mean split decision-making.

3. When there is no time, make the time.

4. Contextualize the risk of heart disease or stroke. One way to provide meaningful perspective is to compare a patient's likelihood of suffering a heart attack or stroke to someone of the same age, gender and race, who has optimal risk factors.

5. Aim for the highest tolerable dose of statins, unless the patient is predisposed to side effects or taking interacting medications.

6. Pay attention to news about statins and heart disease.

This study is published in the Journal of the American College of Cardiology.

Source: Medindia


Recommended Reading

Latest Drug News

 FDA Issues Warning About Compounded Diabetes Drug Semaglutide Products
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

How Much Statins Should be Given to Patients with Heart Disease? Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests